Neuland Laboratories Limited — Important, 04-07-2025: Updates

Neuland Laboratories has announced a board meeting on the financial results for the quarter and half-year. The company operates solely in the Active Pharmaceutical Ingredients (API) manufacturing segment, with exports contributing approximately 68% of revenue. It maintains 4 plants and 3 offices across India and abroad. Neuland continues its focus on sustainability with zero liquid discharge systems across plants, achieving zero waste to landfill through recycling and co-processing. The company has strengthened ESG commitments, including reductions in greenhouse gas emissions via fuel transition and energy conservation measures. Employee well-being and workplace safety remain priorities, with full ISO 45001 certification and zero workplace injuries reported. CSR initiatives target education, women empowerment, healthcare, and water conservation benefiting local communities. No fines or regulatory penalties were recorded, and ethical conduct policies are robustly enforced.